EHRA Premium Access

Chairperson conclusion & Closing question

Topic: Ventricular Arrhythmias and SCD - Pathophysiology and Mechanisms - Ion Channel Disorders

Congress Presentation

11 more presentations in this session

Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - PRO

Speaker: Professor V. Probst (Nantes, FR)

Thumbnail

Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - CON

Speaker: Professor S. Viskin (Tel Aviv, IL)

Thumbnail

Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - Rebuttal PRO

Thumbnail

Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - Rebuttal CON

Thumbnail

Access the full session

Controversies in channelopathy

Speakers: Professor V. Probst, Professor S. Viskin
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations